Acute Leukemia of Ambiguous Lineage — Trials

Acute Leukemia of Ambiguous Lineage — Trials · CancerIndex

Clinical trials

Registered studies

139 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 65
Recruiting: 38
Ph III recruiting: 2
Growth YoY: —
Industry share: 14%
Top sponsor: Fred Hutchinson Cancer Center
Termination share: 35.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (20)

clinicaltrialsPublishedShowing 1–10 of 10 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05589896	A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies	active not recruiting	Phase 1 / Phase 2	12	Ossium Health, Inc.INDUSTRY	1	Sep 10, 2026	clinicaltrials
NCT02159495	Genetically Modified T-cell Immunotherapy in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia and Persistent/Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm	active not recruiting	Phase 1	31	City of Hope Medical CenterOTHER